# Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

> **NCT01328925** · PHASE2 · COMPLETED · sponsor: **Romark Laboratories L.C.** · enrollment: 100 (actual)

## Conditions studied

- Rotavirus Infection
- Viral Gastroenteritis Due to Rotavirus

## Interventions

- **DRUG:** Nitazoxanide

## Key facts

- **NCT ID:** NCT01328925
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328925, "Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01328925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*